Compounds of formula (I) as serine protease inhibitors

Details for Australian Patent Application No. 2008219271 (hide)

Owner Novartis AG

Inventors Zimmermann, Kaspar; Baeschlin, Daniel Kaspar; Moussaoui, Saliha

Agent Davies Collison Cave

Pub. Number AU-A-2008219271

PCT Pub. Number WO2008/101953

Priority 07102910.2 22.02.07 EP

Filing date 20 February 2008

Wipo publication date 28 August 2008

International Classifications

C07D 211/06 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 207/06 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/101953 Priority application(s): WO2008/101953

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008219273-Catalyst for electrochemical reduction of oxygen

2008219269-Combination therapy using TNF and alfa-galactosyl ceramide